BRD2 and ovarian carcinoma: Previous studies have shown that HIF1A is activated in FSH-stimulated ovarian cancer cells SKOV-3 [59], as well as in mouse granulosa cells where HIF1A was shown to be an inducible factor after FSH treatment in vivo and in vitro [60].